Document:

Exhibit 10.13

 

THE SECURITIES DESCRIBED HEREIN HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER
RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

 

THE PURCHASE OF THE SECURITIES INVOLVES
A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement
(this “Agreement”) is entered into as of June [_], 2018 between LF Capital Acquisition Corp., a Delaware corporation
(the “Company”), Level Field Capital, LLC, a Delaware limited liability company (the “Sponsor”),
and [PURCHASER] (the “Purchaser”).

 

RECITALS

 

WHEREAS, the Company
was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization
or similar business combination with one or more businesses (a “Business Combination”);

 

WHEREAS, the Company
has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1
(the “Registration Statement”) for its initial public offering (“IPO”) of units (the “Public
Units”), at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s Class A
common stock, par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common Stock included
in the Public Units, the “Public Shares”), and one warrant, where each warrant is exercisable to purchase one
share of Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment (the “Warrants”,
and the Warrants included in the Public Units, the “Public Warrants”);

 

WHEREAS, proceeds from
the IPO and the sale of the Private Placement Warrants (as defined below) in an aggregate amount equal to the gross proceeds from
the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”),
as described in the Registration Statement;

 

WHEREAS, following
the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS, in connection
with the IPO, the Sponsor and the Purchaser will purchase, in a private placement that will close simultaneously with the IPO Closing,
warrants which are identical to the Warrants except that they will be non-redeemable and exercisable on a cashless basis so long
as they are held by the Sponsor, the Purchaser or their respective permitted transferees (the “Private Placement Warrants”)
for a purchase price of $1.00 per Private Placement Warrant;

 

     

     

    

  

WHEREAS, the parties
wish to enter into this Agreement, pursuant to which the Purchaser shall subscribe for and purchase (i) a portion of the total
number of shares of Class B common stock, par value $0.0001 per share, of the Company (“Class B Common Stock”
and collectively with the shares of Class A Common Stock, the “Common Stock”) to be issued prior to the IPO
(“Founder Shares”) and (ii) Private Placement Warrants (together with the Founder Shares, the “Subscribed
Securities”); and

 

WHEREAS, the Company
has entered into or intends to concurrently with this Agreement enter into agreements (collectively, the “Subscription
Agreements”) in the form of this Agreement with certain affiliates of the Purchaser (together with the Purchaser, the
“Subscribing Parties”) for the purchase of Founder Shares and Private Placement Warrants.

 

NOW, THEREFORE, in
consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other
good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree
as follows:

 

AGREEMENT

 

1.           Sale
and Purchase.

 

(a)          Securities.

 

(i)          Subject
to the terms and conditions hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and
the Company agrees to issue and sell to the Purchaser, the number of Subscribed Securities set forth on the signature page hereto
for the aggregate purchase price set forth on the signature page hereto (the “Purchase Price”). The Purchaser
acknowledges that the Subscribed Securities, and any securities of the Company that may be distributed to the Purchaser on account
of the Subscribed Securities (collectively, the “Securities”), will be subject to restrictions on transfer as
set forth in this Agreement.

 

(ii)         On
the date hereof, (A) the Company shall issue to the Purchaser the number of Founder Shares set forth on the signature page hereto,
in consideration for the Purchaser’s payment of the portion of the Purchase Price applicable to such Founder Shares, as set
forth on the signature page hereto, by wire transfer of immediately available funds or other means approved by the Company, and
(B) the Sponsor shall forfeit to the Company for cancellation, for no consideration, and have no further right, title or interest
in, an equal number of Founder Shares. If the IPO Closing has not occurred by July 31, 2018, then the Company will promptly redeem
the Purchaser’s Founder Shares issued pursuant to this Section 1(a)(ii) for a cash payment equal to the Purchase Price paid
by the Purchaser in respect of such Founder Shares.

 

(iii)        The
Company shall notify the Purchaser in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective
Date”) at least three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit
the balance of the Purchase Price to the Company’s transfer agent (to be held in escrow pending the IPO Closing), by wire
transfer of immediately available funds or other means approved by the Company, on the date that is one Business Day prior to the
Effective Date, or such other date as the Company and the Purchaser may agree upon in writing. As used herein, “Business
Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions
are generally authorized or required by law or regulation to close in the City of New York, New York. If the IPO Closing has not
occurred by the date that is seven (7) Business Days after the date on which the Purchaser remitted the balance of its Purchase
Price to the Company’s transfer agent, then, unless the Purchaser otherwise agrees in writing, the Company will promptly
cause its transfer agent to return such amounts to the Purchaser.

 

     

     

    

  

(iv)        On
the date of the IPO Closing, the Company shall issue to the Purchaser the number of Private Placement Warrants set forth on the
signature page hereto.

 

(b)          Delivery
of Securities.

 

(i)          The
Company shall register the Purchaser as the owner of the Subscribed Securities with the Company’s transfer agent by book
entry on or promptly after (but in no event more than two (2) Business Days after) the date on which such securities are issued
to the Purchaser (provided that prior to the Company’s appointment of a transfer agent it shall register the Purchaser as
the owner of such securities in the Company’s stock ledger upon issuance thereof).

 

(ii)         Each
register and book entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall
be stamped or otherwise imprinted with a legend, in substantially the following form:

 

“THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS
OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.

 

THE SALE, PLEDGE,
HYPOTHECATION, OR TRANSFER OF THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION
AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST
TO THE SECRETARY OF THE COMPANY.”

 

(c)          Legend
Removal. Following the expiration of the transfer restrictions set forth in Section 5(a), if the Securities are eligible
to be sold without restriction under, and without the Company being in compliance with the current public information requirements
of, Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), or if they are registered
for resale under the Securities Act pursuant to a shelf registration statement, then at the Purchaser’s request, the Company
will use best efforts to cause the Company’s transfer agent to remove the legend set forth in Section 1(b)(ii), subject to
compliance by the Purchaser with such reasonable procedures for such removal required by the Company or its transfer agent. In
connection therewith, if required by the Company’s transfer agent, the Company will promptly cause an opinion of counsel
to be delivered to and maintained with its transfer agent, together with any other authorizations, certificates and directions
required by the transfer agent that authorize and direct the transfer agent to issue such Securities without any such legend.

 

     

     

    

 

 

(d)          Registration
Rights. On the Effective Date, the Company shall enter into a Registration Rights Agreement (the “Registration Rights
Agreement”) with the Sponsor and the Subscribing Parties, in substantially the form provided to the Purchaser prior to
the date hereof. The Registration Rights Agreement shall provide the Purchaser with registration rights that are no less favorable
to the Purchaser than the registration rights of the Sponsor set forth therein.

 

2.            Potential
Forfeiture.

 

(a)          If
(i) on the date set for the vote by the Company’s stockholders to approve the Business Combination or (ii) on the Business
Day (as defined below) immediately prior to the scheduled closing of the Business Combination (each, a “Determination
Date”), the Purchaser beneficially owns or holds, directly or indirectly, including through any firm commitments to purchase,
a number of Public Shares (the lesser number of Public Shares so beneficially owned by the Purchaser on either Determination Date,
the “Determination Date Shares”) that is less than the Forfeiture Threshold (as defined below), then (1) the
Purchaser shall automatically transfer to the Sponsor for no consideration, and have no further right, title or interest in, a
pro rata number of its Founder Shares, and (2) the Sponsor (or its designee, provided that any designee shall be subject
to the approval of the Purchaser, such approval not to be unreasonably withheld) shall have the obligation to purchase from the
Purchaser a pro rata number of the Purchaser’s Private Placement Warrants for a purchase price of $1.00 per Private
Placement Warrant, in each case calculated as a fraction, the numerator of which is the number of Shortfall Shares (as defined
below) and the denominator is the Forfeiture Threshold. For the avoidance of doubt, in calculating the number of Public Shares
(if any) which the Purchaser beneficially owns or holds, directly or indirectly, for purposes of determining the number of Determination
Date Shares, no Public Shares that are beneficially owned by any other Subscribing Party shall be counted (e.g., no Public Shares
shall be double counted among Subscribing Parties). The Purchaser shall take all actions as may be reasonably necessary to consummate
any transfer and/or sale contemplated by this Section 2, including entering into agreements and delivering certificates
and instruments and consents as may be deemed by the Company to be necessary or appropriate (which shall not require the Purchaser
to make any representations other than as to its clear title to the applicable Founder Shares and/or Private Placement Warrants
and its power and authorization to effect the transactions contemplated by the applicable agreement or other instrument), and the
Purchaser hereby grants to the Company and any representative designated by the Company without further action by the Purchaser
a limited irrevocable power of attorney to effect any transfer contemplated hereby on behalf of the Purchaser, which power of attorney
shall be deemed to be coupled with an interest.

 

(b)          As
used herein, (i) the “Forfeiture Threshold” shall initially mean [_] shares of Class A Common Stock; provided,
that if the actual number of Public Units offered and sold in the IPO is less than 13,500,000 (without regard to the over-allotment
option), then the Forfeiture Threshold shall be automatically reduced on a pro rata basis, and (ii) the “Shortfall Shares”
shall mean the amount by which the Forfeiture Threshold exceeds the Determination Date Shares.

 

     

     

    

  

(c)          Solely
by way of example to illustrate the provisions of Section 2(a), if the Forfeiture Threshold is 1,350,000 and on each Determination
Date the Purchaser beneficially owns 810,000 shares of Public Shares (such that the number of Determination Date Shares is 810,000),
then the number of Shortfall Shares shall be 540,000, and the percentage of (i) the Purchaser’s Founder Shares that the Purchaser
would transfer to the Sponsor and (ii) the Purchaser’s Private Placement Warrants that the Sponsor (or its designee) would
have the obligation to purchase for a purchase price of $1.00 per Private Placement Warrant would be 40% (e.g., 540,000 divided
by 1,350,000).

 

3.           Representations
and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows,
as of the date hereof:

 

(a)          Organization
and Power. The Purchaser is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation
and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b)          Authorization.
The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser,
will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with
its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any
other laws of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies.

 

(c)          Governmental
Consents and Filings. No consent, approval, order or authorization of, or registration, qualification, designation, declaration
or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection
with the consummation of the transactions contemplated by this Agreement, except for filings pursuant to applicable securities
laws, rules or regulations.

 

(d)          Compliance
with Other Instruments. The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the
Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions
of its organizational documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it
is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement,
contract or purchase order to which it is a party or by which it is bound or (v) of any provision of federal or state statute,
rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect
on the Purchaser’s ability to consummate the transactions contemplated by this Agreement.

 

(e)          Purchase
Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the
Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired
by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with
a view to the resale or distribution of any part thereof in violation of any state or federal securities laws, and that the Purchaser
has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of law. By
executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking,
agreement or arrangement with any Person (other than the Company) to sell, transfer or grant participations to such Person or to
any third Person, with respect to any of the Securities. For purposes of this Agreement, “Person” means an individual,
a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other
entity or any government or any department or agency thereof.

 

     

     

    

  

(f)          Disclosure
of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and
the terms and conditions of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the
Company’s management.

 

(g)          Restricted
Securities. The Purchaser understands that the offer and sale of the Securities to the Purchaser has not been and will not be registered
under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends
upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations
as expressed herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S.
federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless
they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements
is available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities except pursuant
to the Registration Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification
is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the
holding period for the Securities, and on requirements relating to the Company which are outside of the Purchaser’s control,
and which the Company is under no obligation and may not be able to satisfy. The Purchaser acknowledges that the Company has confidentially
submitted the Registration Statement for its proposed IPO. The Purchaser understands that the offering of Securities and transactions
contemplated hereunder are not and are not intended to be part of the IPO, and that the Purchaser will not be able to rely on the
protection of Section 11 of the Securities Act with respect to its purchase of Securities hereunder.

 

(h)          No
Public Market. The Purchaser understands that no public market now exists for the Securities, and that the Company has not made
any assurances that a public market will ever exist for the Securities.

 

(i)          High
Degree of Risk. The Purchaser understands that the purchase of the Subscribed Securities involves a high degree of risk which could
cause the Purchaser to lose all or part of its investment.

 

(j)          Accredited
Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

 

(k)          No
General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has
either directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general solicitation,
or (ii) published any advertisement in connection with the offer and sale of the Securities.

 

     

     

    

  

(l)          Place
of Investment Decision. The Purchaser’s investment decision was made in the office or offices located at the address of the
Purchaser set forth on the signature page hereof.

 

(m)          Adequacy
of Financing. The Purchaser will, when such funds are due hereunder, have sufficient funds to satisfy its obligations under
this Agreement.

 

(o)          No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section
3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of
the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed
to make any other express or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by
the Company in Section 4 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties
specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Company,
any person on behalf of the Company or any of the Company’s affiliates (collectively, the “Company Parties”)
with respect to the transactions contemplated hereby.

 

4.            Representations
and Warranties of the Company. The Company represents and warrants to the Purchaser as follows:

 

(a)          Organization
and Corporate Power. The Company is incorporated and validly existing and in good standing as a corporation under the laws of Delaware
and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b)          Capitalization.
The authorized share capital of the Company consists, as of the date hereof:

 

(i)          100,000,000
shares of Class A Common Stock;

 

(ii)         15,000,000
shares of Class B Common Stock, 3,881,250 of which are issued and outstanding and held by the Sponsor and the Company’s independent
director nominees. All of the outstanding 3,881,250 shares of Class B Common Stock have been duly authorized, are fully paid and
nonassessable and were issued in compliance with all applicable federal and state securities laws.

 

(iii)        1,000,000
shares of preferred stock, none of which are issued and outstanding.

 

(c)          Authorization.
All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to authorize the
Company to enter into this Agreement, and to issue the Subscribed Securities, has been taken on or prior to the date hereof. All
action on the part of the stockholders, directors and officers of the Company necessary for the execution and delivery of this
Agreement, the performance of all obligations of the Company under this Agreement, and the issuance and delivery of the Subscribed
Securities has been taken on or prior to the date hereof. This Agreement, when executed and delivered by the Company, shall constitute
the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms except (i)
as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application
relating to or affecting the enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief, or other equitable remedies.

 

     

     

    

  

(d)          Valid
Issuance of Securities.

 

(i)          The
Subscribed Securities, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this
Agreement, will be validly issued and fully paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances
and charges with respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under
this Agreement, applicable state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser.
Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to the filings described in Section
4(e) below, the Subscribed Securities will be issued in compliance with all applicable federal and state securities laws.

 

(ii)         No
“bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below),
except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered
Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the
Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

(e)          Governmental
Consents and Filings. Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local
governmental authority is required on the part of the Company in connection with the consummation of the transactions contemplated
by this Agreement, except for filings pursuant to Regulation D of the Securities Act, applicable state securities laws, if any.

 

(f)          Compliance
with Other Instruments. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in any violation or default (i) of any provisions of the certificate of incorporation, bylaws
or other governing documents of the Company, (ii) of any instrument, judgment, order, writ or decree to which the Company is a
party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound,
(iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) of any
provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which
would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

     

     

    

  

(g)          Operations.
As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations
other than organizational activities and activities in connection with offerings of the Securities.

 

(h)          Foreign
Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the
Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision
of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment to any foreign or domestic government official or employee.

 

(i)          Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with
applicable financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering
laws and regulations, including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the USA Patriot Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency
(collectively, the “Anti-Money Laundering Laws”), and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is
pending or, to the knowledge of the Company, threatened.

 

(j)          Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government
agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company
or any of the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as
such.

 

(k)          No
General Solicitation. Neither the Company, nor any of its officers, managers, employees, agents or members has either directly
or indirectly, including, through a broker or finder (i) engaged in any general solicitation, or (ii) published any advertisement
in connection with the offer and sale of the Subscribed Securities.

 

(l)          Non-Public
Information. The Company represents and warrants that none of the information conveyed to the Purchaser in connection with
the transactions contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness
of the Registration Statement.

 

(m)          No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section
4 and in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed
to make any other express or implied representation or warranty with respect to the Company or the offering of Securities hereunder,
and the Company Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly
made by the Purchaser in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company
Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the
Purchaser Parties.

 

     

     

    

  

5.           Additional
Agreements and Acknowledgements of the Purchaser.

 

(a)          Transfer
Restrictions. The Purchaser agrees that it shall not Transfer (as defined below) (i) any Founder Shares until the earlier of
(A) one year after the closing of a Business Combination (the “Business Combination Closing) and (B) the date following
the Business Combination Closing on which the Company completes a liquidation, merger, stock exchange or other similar transaction
that results in all of the Company’s stockholders having the right to exchange their Common Stock for cash, securities or
other property (the “Lock-up Period”) or (ii) any Private Placement Warrants until 30 days after the completion
of a Business Combination. Notwithstanding the foregoing, if subsequent to a Business Combination, the closing price of the Class
A Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations
and the like) for any twenty (20) trading days within any thirty (30) trading day period commencing at least one hundred and fifty
(150) days after the Business Combination Closing, the Founder Shares shall be released from the lockup referenced herein. Notwithstanding
the first sentence hereinabove, Transfers of the Securities are permitted (i) to any other person or entity that holds Common Stock
prior to the consummation of the IPO; (ii) to the Company’s officers, directors or employees; (iii) in the case of an entity,
as a distribution to its partners, stockholders or members upon liquidation; (iv) in the case of an individual, by gift to a member
of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate
family, for estate planning purposes; (v) in the case of an individual, by virtue of laws of descent and distribution upon death
of the individual; (vi) in the case of an individual, pursuant to a qualified domestic relations order; (vii) by pledges to secure
obligations incurred in connection with purchases of the Company’s securities; (viii) by private sales or transfers made
in connection with the consummation of a Business Combination at prices no greater than the price at which the applicable Securities
were originally purchased; (ix) in the event of the Company’s liquidation, bankruptcy or dissolution prior to the completion
of a Business Combination; (x) in the event of completion of a liquidation, merger, stock exchange or other similar transaction
which results in all of the Company’s stockholders having the right to exchange their Common Stock for cash, securities or
other property subsequent to the completion of a Business Combination; (xi) to the Purchaser’s affiliates, to any investment
fund or other entity controlled or managed by the Purchaser, or to any investment manager or investment advisor of the Purchaser
or an affiliate of any such investment manager or investment advisor; (xi) to a nominee or custodian of a person or entity to whom
a disposition or transfer would be permissible under clauses (i) through (x) above; and (xii) pursuant to the provisions of Section
2 of this Agreement (each of the foregoing, a “Permitted Transferee”); provided, however, that in the case of
clauses (i) through (xi), these permitted transferees must enter into a written agreement agreeing to be bound by the terms of
this Agreement, including the forfeiture provisions of Section 2 and these transfer restrictions. As used in this Agreement, “Transfer”
shall mean the (x) sale of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position (within the meaning of Section 16 of the Exchange Act,
and the rules and regulations of the SEC promulgated thereunder) with respect to, any of the Securities; (y) entry into any swap
or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the
Securities, whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or (z) public announcement
of any intention to effect any transaction specified in clause (x) or (y); provided, that this Section 5(a) shall not prohibit
the Purchaser from effecting a Short Sale (as defined below) with securities that do not constitute “Securities” under
this Agreement.

 

     

     

    

  

(b)          Trust
Account.

 

(i)          The
Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account for the benefit of its public
stockholders upon the IPO Closing. The Purchaser hereby agrees that it has no right, title, interest or claim of any kind in or
to any monies held in the Trust Account, or any other asset of the Company as a result of any liquidation of the Company, except
for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it.

 

(ii)         The
Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account
that it may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect
of any Public Shares held by it. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser
shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any
monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public
Shares held by it.

 

(c)          No
Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf, will engage in any Short
Sales with respect to securities of the Company prior to the closing of the Business Combination. For purposes of this Section
5.1(d), “Short Sales” shall include, without limitation, all “short sales” as defined in Rule 200 promulgated
under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges (other than pledges in the ordinary
course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements
(including on a total return basis).

 

(d)          Use
of Purchaser’s Name. Neither the Company nor the Sponsor will, without the written consent of the Purchaser in each instance,
use in advertising, publicity or otherwise the name of the Purchaser or any of its affiliates, or any director, officer or employee
of the Purchaser, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation
thereof owned by the Purchaser or its affiliates or any information relating to the business or operations of the Purchaser or
its affiliates (including, for the avoidance of doubt, any investment vehicles, funds or accounts managed thereby). Notwithstanding
the foregoing, the Company may disclose (i) Purchaser’s name and information concerning the Purchaser (A) to the extent required
by law, regulation or regulatory request, including in the Registration Statement to the extent required by the rules or regulations
of the SEC applicable thereto or pursuant to a request for such disclosure from the Staff of the SEC or FINRA or (B) to the Company’s
lawyers, independent accountants and to other advisors and service providers who reasonably require Purchaser’s information
in connection with the provision of services to the Company, are advised of the confidential nature of such information and are
obligated to keep such information confidential, and (ii) Purchaser’s name and the terms of this Agreement to the other Subscription
Parties. The Company and the Sponsor agree to provide to the Purchaser for Purchaser’s review any disclosure in any registration
statement or other document in advance of the submission, filing or disclosure of such document in connection with the transactions
contemplated by this Agreement with respect to the Purchaser or any of its affiliates, and will not make any such submission, filing
or disclosure without including any revisions reasonably requested by the Purchaser or if the Purchaser has a good faith objection
to such submission, filing or disclosure.

 

     

     

    

  

(e)          Stock
Exchange Listing. The Company will use commercially reasonable efforts to effect and maintain the listing of the Class A Common
Stock and Warrants on The Nasdaq Capital Market (or another national securities exchange) until the third anniversary of the consummation
of a Business Combination.

 

6.           General
Provisions.

 

(a)          Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic
mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours, then on
the recipient’s next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return
receipt requested, postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier,
freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company
shall be sent to: LF Capital Acquisition Corp., 600 Madison Avenue, New York, NY 10022, Attention: Chief Executive Officer, Email:
pdebacker@lfcapital.co, with a copy to Venable LLP, 1270 Avenue of the Americas, New York, NY 10020, Attention: William N. Haddad,
Email: wnhaddad@venable.com.

 

All communications
to the Purchaser shall be sent to the Purchaser’s address as set forth on the signature page hereof, or to such email address,
facsimile number (if any) or address as subsequently modified by written notice given in accordance with this Section 6(a).

 

(b)          No
Finder’s Fees. Each party represents that it neither is nor will be obligated for any finder’s fee or commission in
connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any
commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs
and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees
or representatives are responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability for any
commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs
and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees
or representatives is responsible.

 

     

     

    

  

(c)          Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive the consummation of
the transactions contemplated by this Agreement.

 

(d)          Entire
Agreement. This Agreement, together with any other documents, instruments and writings that are delivered pursuant hereto or referenced
herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes
all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate
in any way to the subject matter hereof or the transactions contemplated hereby.

 

(e)          Successors.
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure
to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights,
remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f)          Assignments.
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests,
or obligations hereunder without the prior written approval of the other party.

 

(g)          Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together
will constitute one and the same instrument.

 

(h)          Headings.
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or
interpretation of this Agreement.

 

(i)          Governing
Law. This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether grounded in
contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws
of the State of New York, without giving effect to its choice of laws principles.

 

(j)          Jurisdiction.
The parties hereby irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United
States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out
of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this
Agreement except in state courts of New York or the United States District Court for the Southern District of New York, and (iii)
waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim
that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment
or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding
is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

     

     

    

  

(k)          WAIVER
OF JURY TRIAL. THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT
AND THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(l)          Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of
the Company and the Purchaser.

 

(m)          Severability.
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect
the validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to
any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable
in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination
will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete
specific words or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(n)          Expenses.
Each of the Company and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution
and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses
of agents, representatives, financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of
its transfer agent, stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Securities
and the securities issuable upon conversion or exercise of the Securities.

 

(o)          Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of
intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption
or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement.
Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations
promulgated thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be
construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless
the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
“hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless
expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent
significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact
that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative
levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto
is in breach of the first representation, warranty, or covenant.

 

     

     

    

  

(p)          Waiver.
No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional
or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder
or affect in any way any rights arising because of any prior or subsequent occurrence.

 

(q)          Specific
Performance. Each party hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not performed
by the other party hereto in accordance with the terms hereof and that the such party shall be entitled to specific performance
of the terms hereof, in addition to any other remedy at law or equity.

 

(r)          Confidentiality.
Except as may be required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the
provisions of Section 5(d) hereof), unless and until the transactions contemplated hereby and the terms hereof are publicly announced
or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the
existence or terms of this Agreement. Notwithstanding the foregoing, the Purchaser shall be permitted to disclose any information
to its affiliates and its and their respective directors, officers, employees, advisors, director or indirect owners, agents and
representatives, in each case so long as such person or entity has been advised of the confidentiality obligations hereunder; provided
that the Purchaser shall be liable for any breach of such confidentiality obligations by any such person or entity.

 

[Signature Pages Follow]

 

     

     

    

 

IN WITNESS WHEREOF,
the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	LF CAPITAL ACQUISITION CORP.

 

	 	By:	 

	 	Name:
	 	Title:
	 	 
	 	Purchaser’s Address for Notices:
	 	 
	 	LF Capital Acquisition Corp.
	 	600 Madison Avenue
	 	New York, NY 10022
	 	 
	 	with copies to:
	 	 
	 	Venable LLP
	 	1270 Avenue of the Americas
	 	New York, NY 10020
	 	Attn: William N. Haddad
	 	Email: wnhaddad@venable.com
	 	Fax: (212) 307-5598

 

     

     

    

 

PURCHASER:

 

	 	[PURCHASER]

 

	 	By:	 
	 	 
	 	Name:
	 	 
	 	Title:

 

Subscribed Securities:

 

	 	 	Number
    of 
 Subscribed Securities	 	 	Purchase Price	 
	Founder Shares	 	 		 	 	 		 
	Private Placement Warrants	 	 	 	 	 	 	 	 

 

	 	Purchaser’s Address for Notices:
	 	 
	 	[_]
	 	 
	 	 
	 	with copies to:
	 	 
	 	Winston & Strawn LLP
	 	200 Park Avenue
	 	New York, NY 10166
	 	Attn: Joel L. Rubinstein
	 	Email: jrubinstein@winston.com
	 	Fax: (212) 294-4700

 

     

     

    

  

	 	SPONSOR:
	 	 
	 	LEVEL FIELD CAPITAL, LLC

 

	 	By:	 

 

	 	Name:
	 	 
	 	Title:Exhibit 10.9

 

CONSULTING AGREEMENT

 

THIS CONSULTING
AGREEMENT (this “Agreement”) is made as of May 25, 2018, between ADVX INVESTORS GROUP LLC., a Delaware Limited
Liability Company (the “Consultant”), Jeffrey Busch (the “Designated Person”) and AVANT DIAGNOSTICS,
INC., a Nevada corporation (the “Company”).

 

RECITALS

 

WHEREAS, Consultant
has expertise in the area of the Company’s business and is willing to provide consulting services to the Company; and

 

WHEREAS, the Company
desires to retain the Consultant, and the Consultant agrees to be retained by the Company, upon the terms and conditions hereinafter
set forth.

 

NOW, THEREFORE, in
consideration of the mutual covenants and promises contained herein, the parties hereto, each intending to be legally bound hereby,
agree as follows:

 

1.
Terms and Conditions of Engagement.

 

a. Engagement.
The Consultant shall perform such consulting and advisory services as the Company or any of its subsidiaries may reasonably require
from time to time, including but not limited to acquisitions, business development, management and sales services, and related
services pertaining to the Company’s business. During the term of this Agreement, Designated Person shall perform the services
on behalf of Consultant; Designated Person shall devote such time, attention and energy to the business and affairs of the Company
as shall be necessary to perform the services specified herein. Consultant and Designated Person shall report to and follow the
instructions of the full Board of Directors of the Company.

 

b. Contractor
Relationship. The parties acknowledge and agree that the Consultant is an independent contractor to the Company, not an employee
of the Company. The Consultant is not an agent of the Company and shall have no right to bind the Company. The Consultant shall
not be treated for any purposes as an employee of the Company. The Company will report all payments to be made hereunder on Form
1099 as payments to the Consultant for independent contracting services, and will not report any payments on Form W-2 to the Consultant,
unless the Company is lawfully required to do so upon the advice of its auditors or tax advisors. The Consultant and Designated
Person each agree to indemnify the Company with respect to all income taxes and payroll taxes, including all penalties and interest
assessed against the Company, if any, with respect to the Consultant’s payments under this Agreement. This is a personal
services contract for the services of the Designated Person to perform the services on behalf of Company, as agent of Consultant.
The Consultant cannot satisfy the terms and conditions of this Agreement by making anyone else available to perform the services
other than the Designated Person. The Company shall have no right to control the manner or means by which Consultant performs services
hereunder; however, the Consultant shall devote sufficient business time and efforts to the performance of services for the Company
to complete the services within the time frames for completion established by the Company. The Consultant shall use its best efforts
in such endeavors. The Consultant shall also perform its services with a level of care, skill, and diligence that a prudent professional
acting in a like capacity and familiar with such matters would use.

 

2.
Compensation.

 

a. Base
Compensation. The Company shall pay the Consultant base compensation starting at a monthly rate of Thirteen Thousand Three
Hundred and Thirty-Three Dollars and Thirty-Three cents ($13,333.33) (the “Base Compensation”). The Base Compensation
shall be paid in accordance with the normal payment practices for consultants of the Company as in effect from time to time, but
in no event less often than monthly. The Base Compensation shall be payable in either cash or shares of the Company’s common
stock (the “Common Stock”), at the sole discretion of the Company. To the extent the Company does not have a
sufficient number of authorized shares of Common Stock available to issue to Consultant, the Company may issue the Consultant shares
of the Company’s series A preferred stock, which has such rights, designations and preferences as set forth in Exhibit A
annexed hereto (the “Preferred Stock” and together with the shares of Common Stock, the “Shares”).
Any Shares to be issued by the Company in satisfaction of the Base Compensation shall be made on a monthly basis, with the exact
number of Shares to be issued to be determined based upon the average of the closing price of the Company’s Common Stock
on the five (5) trading days immediately preceding the date such payment shall be made..

 

    	 	-1-	 

     

    

 

b. Business
Expenses. The Company shall promptly reimburse the Consultant for all travel, meals, entertainment and other ordinary and necessary
business expenses incurred by the Consultant in the performance of his duties to the Company; provided, that such expenses
are incurred and accounted for in accordance with the policies and procedures established by the Company.

 

3. Term.
The term of this Agreement (the “Term”) shall begin on the date of execution (the “Commencement Date”),
and shall continue for six months unless terminated sooner in accordance with Section 4. Thereafter, this Agreement shall automatically
renew on a month-to-month basis unless either party gives notice of non-renewal to the other at least fifteen (15) days prior to
an anniversary of the Commencement Date. Notwithstanding the foregoing, the term of this Agreement shall not extend beyond the
twelve (12) month anniversary of the Commencement Date.

 

4. Termination.
Consultant or the Company may terminate this Agreement at any time and the Company may terminate the Designated Person at any time,
with or without cause or good reason, by giving thirty (30) days prior written notice to the other party. The obligations set forth
in Sections 5, 6, 7, 9 and 10 shall survive any termination or expiration of this Agreement. Upon termination, of this Agreement,
Consultant and Designated Person shall promptly deliver to the Company all documents and other materials of any nature pertaining
to the Company, together with all documents and other items containing or pertaining to any Confidential Information (as defined
below) and Company Work Product (as defined below).

 

5. Confidential
Information.

 

a. At
all times, both during the term of this Agreement and thereafter, Consultant and Designated Person shall hold in strictest confidence
and shall not disclose, lecture upon or publish any of the Company’s Confidential Information (defined below), except to
the extent such disclosure, use or publication is expressly authorized in writing by an officer of the Company or as required by
applicable law or regulation or the order of a court or other governmental body having jurisdiction over such matter. Consultant
and Designated Person shall use such Confidential Information only as may be required in direct connection with Consultant’s
performing the requested Services for the Company.

 

b. The
term “Confidential Information” shall mean trade secrets, confidential knowledge, data and any other proprietary information
that the Company owns, licenses or has obtained from third parties to whom the Company owes a duty of confidentiality with respect
to such information. By way of illustration but not limitation, “Confidential Information” includes: (i) inventions,
trade secrets, ideas, data, programs, works of authorship, know-how, improvements, processes, discoveries, designs, techniques
and other sensitive information the Company receives from its customers or other third parties; (ii) technical information relating
to the Company’s existing and future products, including, where appropriate and without limitation, financial techniques
and procedures, financial production, software, firmware, information, patent disclosures, patent applications, development or
experimental work, formulae, engineering or test data, product specifications, structures, models, techniques, processes and apparatus
relating to the same disclosed by the Company to Consultant or obtained by Consultant through observation or examination of information
or developments; (iii) confidential marketing information (including without limitation marketing strategies, customer names and
requirements and products and services, prices, margins and costs); (iv) confidential future product plans; (v) confidential financial
information provided to Consultant by the Company; (vi) personnel information (including without limitation employee compensation);
and (vii) other confidential business information of the Company or any third party. Notwithstanding the foregoing, nothing received
by Consultant shall be considered to be Confidential Information if (x) it has been published or is otherwise readily available
to the public other than by a breach of this Agreement, (y) it has been rightfully received by Consultant from a third party without
any confidentiality limitations, or (z) it was known by the Consultant, as evidenced by his or her records, prior to its disclosure
by the Company.

 

    	 	-2-	 

     

    

 

6.
Intellectual Property Rights.

 

a. Consultant
and Designated Person agree that any and all inventions, trade secrets, ideas, data, programs, works of authorship, know-how, improvements,
processes, discoveries, designs, techniques, and related information (collectively, “Inventions”), whether or
not patentable or copyrightable, that the Consultant or Designated Person conceive or perfect: (1) as part of performing services
for the Company under this Agreement or (2) using the Company’s Confidential Information (collectively, the “Company
Work Product”) shall be the sole and exclusive property of the Company. Consultant and Designated Person each hereby
assign and agree to assign to the Company his, her or its entire right, title and interest, including all intellectual-property
rights, in and to such Company Work Product.

 

b. Consultant
and Designated Person agree to execute, when requested, any documents deemed reasonably necessary by the Company to carry out the
purposes of this Agreement. Consultant and Designated Person further agree to assist the Company in every proper way to obtain,
and from time to time enforce, United States and foreign patent and other intellectual property rights relating to Company Work
Product including executing, verifying and delivering such documents and performing such other acts as the Company may reasonably
request from time to time in applying for, obtaining, perfecting, sustaining, defending, and enforcing such rights and the assignment
thereof. Designated Person’s and Consultant’s obligation to assist the Company as described herein shall continue beyond
the termination of this Agreement, provided that the Company shall compensate Consultant and Designated Person at a reasonable
rate after termination of this Agreement for time Consultant actually spends performing the obligations described herein.

 

c. If
the Company is unable, after reasonable effort, to secure Designated Person’s and Consultant’s signature on any document
needed to apply for, obtain, perfect, sustain, defend, or enforce any patents or other intellectual property rights relating to
Company Work Product, Consultant hereby designates and appoints the Company and its duly authorized officers and agents as his
or her agent and attorney in fact, with full power of substitution, to execute, verify and file applications and to do all other
lawfully permitted acts necessary to apply for, obtain, perfect, sustain, defend, or enforce such rights with the same legal force
and effect as if executed by Consultant and Designated Person. Such power of attorney shall be deemed coupled with an interest.

 

d. Consultant
and Designated Person each agree to submit to the Company any proposed publication that contains any discussion relating to the
Company, Confidential Information, Inventions, Company Work Product or work performed by Consultant and/or Designated Person for
the Company hereunder. Consultant and Designated Person further agree that no such publication shall be made without the prior
written consent of the Company.

 

7. Non-Competition;
Non-Solicitation.

 

a. During
the Term and continuing until the twelve month anniversary date after the termination of the Consultant’s position under
this Agreement (the “Restricted Period”), the Consultant and Designated Person shall not, without the prior
written consent of the Company, directly or indirectly, render services of a business, professional or commercial nature (whether
for compensation or otherwise) or lend money to any person or entity competitive with the business engaged in by the Company or
any of its subsidiaries within twelve (12) months prior to such termination of the position, or serve as an officer, director,
employee, partner, member, owner, consultant or independent contractor in any entity which is competitive with the business engaged
in by the Company or any of its subsidiaries within twelve (12) months prior to such termination of his position. Notwithstanding
the foregoing, nothing shall prevent the Consultant or Designated Person from (a) owning publicly traded securities issued by any
such competitive entity, provided that the ownership thereof by the Consultant or Designated Person does not constitute
more than 2% of all of such entity’s publicly traded outstanding securities or (b) being employed by or otherwise involved
with a subsidiary or division, which is not competitive with the business of the Company or any of its subsidiaries, of a company
that is otherwise competitive with the business of the Company or any of its subsidiaries. The Consultant and Designated Person
acknowledge that the restrictions contained in this Section 7 of this Agreement are fair and reasonable to protect the legitimate
interests of the Company, are not unreasonably burdensome to the Consultant or Designated Person, and are supported by adequate
consideration.

 

    	 	-3-	 

     

    

 

b. During
the Restricted Period, Designated Person shall not, directly or indirectly, for himself or on behalf of any other person or entity,
employ, engage or retain any person who at any time during the then immediately preceding 12 month period shall have been an employee
of the Company or any of its subsidiaries (other than any such person whose employment was terminated by the Company prior to such
employment, engagement or retention), or contact any supplier, customer or employee of the Company or any of its subsidiaries for
the purpose of soliciting or diverting any such supplier, customer or employee from its business relationship with the Company
or any of its subsidiaries or otherwise intentionally interfering with the business relationship of the Company or any of its subsidiaries
with any of the foregoing

 

8. Additional
Activities. Each of Consultant and Designated Person hereby represent and warrant that it is not currently engaged in, and
shall not during the term of this Agreement become engaged in, any business activity that involves the development, production,
marketing or selling of products, processes or techniques, or the use of technologies, that are substantially similar to, or competitive
with, products, processes, techniques or technologies of the Company.

 

9. Indemnification.

 

a. If
the Consultant or Designated Person is made a party to or threatened to be made a party to any action, suit or proceeding, whether
civil, criminal, administrative or investigative (a “Proceeding”), by reason of the fact that the Consultant
or Designated Person is or was serving at the request of the Company, or in connection with his service hereunder, as a director,
officer, member, partner, employee, fiduciary, trustee, consultant, representative or agent of another corporation or of a partnership,
joint venture, trust or other enterprise, including service with respect to employee benefit plans, the Consultant and Designated
Person shall be indemnified and held harmless by the Company to the fullest extent permitted by the Company’s certificate
of incorporation, by-laws, or applicable law, as the case may be, on the same basis as all other senior Consultants, against all
Expenses (as defined below) incurred or suffered by the Consultant or Designated Person in connection therewith, and such indemnification
shall continue as to the Consultant and Designated Person even if the Consultant ceases to be a consultant, representative or agent
of the Company, and shall inure to the benefit of Designated Person’s heirs, executors and administrators. The term “Expenses”
shall include reasonable fees, costs, and expenses, losses, judgments, damages, liabilities, fines, penalties, excise taxes, settlements,
reasonable attorneys’ fees and expenses, reasonable accountants’ and other professionals’ fees and expenses,
and reasonable disbursements and costs of attachment or similar bonds, investigations, and any reasonable expenses of establishing
a right to indemnification under this Agreement. Without limiting the foregoing reference to the Company’s Certificate of
Incorporation, By-Laws or applicable law, the right of the Consultant to indemnification is subject to the Consultant’s or
Designated Person’s actions, which form the basis for the Proceeding having been taken in good faith and in a manner the
Consultant or Designated Person reasonably believed to be in or not opposed to the best interest of the Company and, with respect
to any criminal action or proceeding, the Consultant or Designated Person had no reasonable cause to believe that his conduct was
unlawful.

 

b. The
Company shall, within seven (7) days of presentation of invoices or other appropriate documentation, pay all Expenses incurred
in connection with any Proceeding relating to the Consultant’s or Designated Person’s services of the Company or any
other indemnifiable matter; provided that if it is determined in accordance with the Company’s Certificate of Incorporation,
bylaws, this Agreement and/or applicable law that the Consultant is not entitled to reimbursement for all or any part of such Expenses,
the Company shall not be obligated to pay the Expenses, or if paid, the Consultant shall reimburse the Company therefor.

 

    	 	-4-	 

     

    

 

c. Notwithstanding
any other provisions of this Agreement to the contrary, the obligations of the Company under this Section 7 shall continue during
the Term and, after the Consultant ceases to be a Consultant to the Company, during any period which the Consultant or Designated
Person may be liable for acts or omissions as a Consultant to the Company or its subsidiaries or affiliates or any other potentially
indemnifiable matter (but no less than three (3) years after the date of such cessation) on the same basis as all other consultants
of the Company.

 

d. 
The right to indemnification and the payment of Expenses incurred in defending a Proceeding in advance of its final disposition
conferred in this Section 7 shall not be exclusive of any other right which the Consultant or Designated Person may have or hereafter
may acquire under any statute, provision of the certificate of incorporation or by-laws of the Company, agreement, vote of stockholders
or disinterested directors or otherwise.

 

10. Non-Disparagement.
At any time during the Term and thereafter, the Company and/or its subsidiaries or affiliates (collectively, the “Company
Parties”), on the one hand, and the Consultant and Designated Person, on the other hand, shall not make or authorize
any person to make or allow any statement or take any action, public or private, which would disparage or criticize the other party,
including, for example, their character and/or services; provided, however, that nothing contained in this Section 10 shall
preclude any Company Party or the Consultant from making any truthful statement in good faith which is required by any applicable
law or regulation or the order of a court or other governmental body.

 

11. Investment
Representations.

 

a. Consultant
Bears Economic Risk. The Consultant must bear the economic risk of this investment indefinitely unless the Shares are
registered pursuant to the Securities Act of 1933, as amended (the “Securities Act”), or an exemption
from registration is available. The Consultant also understands that there is no assurance that any exemption from registration
under the Securities Act of 1933 will be available and that, even if available, such exemption may not allow the Consultant to
transfer all or any portion of the shares of the common stock of the Company to be received by the Consultant pursuant to this
Agreement under the circumstances, in the amounts or at the times the Consultant might propose.

 

b. Acquisition
for Own Account. The Consultant is acquiring the Shares of the Company to be received by the Consultant pursuant to this Agreement
for its own account for investment only, and not with a view towards distribution.

 

c. The
Consultant Can Protect His Interest. The Consultant represents that by reason of his business or financial experience, the
Consultant has the capacity to protect his own interests in connection with the transactions contemplated by this Agreement. Further,
the Consultant is aware of no publication of any advertisement in connection with the transactions contemplated by this Agreement.

 

d. Company
Information. The Consultant has had an opportunity to discuss the Company’s business, management and financial affairs
with directors, officers and management of the Company and has had the opportunity to review the Company’s operations and
facilities. The Consultant has also had the opportunity to ask questions of and receive answers from the Company and its management
regarding the terms and conditions of this investment.

 

e. Transfer
Restrictions. The Consultant will not sell or otherwise transfer the Shares without registration under the Securities Act or
unless an exemption from registration is available.

 

f. Rule
144. The Consultant acknowledges and agrees that the Shares to be received by the Consultant pursuant to this Agreement must
be held indefinitely unless it is subsequently registered under the Securities Act or an exemption from such registration is available.
The Consultant is aware that the Shares and any shares of Company common stock issued to the Consultant upon exercise of the Options
are “restricted securities,” as such term is defined in Rule 144 promulgated under the Securities Act. The Consultant
has been advised or is aware of the provisions of Rule 144 promulgated under the Securities Act as in effect from time to time,
which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including,
among other things: the availability of certain current public information about the Company, the resale occurring following the
required holding period under Rule 144 and the number of shares being sold during any three-month period not exceeding specified
limitations.

 

    	 	-5-	 

     

    

 

g. No
Representations or Warranties. No representations or warranties have been made to the Consultant by the Company or any officer,
director, employee, agent, affiliate or subsidiary of the Company other than those contained herein, and in accepting shares of
common stock of the Company, the Consultant is not relying on any representations other than those contained herein.

 

h. Legend.
The Consultant understands and acknowledges that any shares of common stock of the Company to be received by the Consultant pursuant
to this Agreement shall bear a legend substantially as follows until such time as (a) such securities shall have been registered
under the Securities Act, or (b) in the opinion of counsel for the Company such securities may be sold without registration under
the Securities Act as well as any applicable state securities laws:

 

“THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED,
HYPOTHECATED, SOLD OR TRANSFERRED UNLESS REGISTERED AND QUALIFIED UNDER THE SECURITIES ACT AND, IF APPLICABLE, STATE SECURITIES
LAWS, OR IN THE OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED.”

 

12. Notice.
All notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly
given when delivered or mailed certified or registered mail, return receipt requested, postage prepaid, and, if to the Consultant
and Designated Person, addressed to them at ____________________, and, if to the Company, addressed to it at 1050 30th
Street NW, Suite 107, Washington, D.C. 20007, Attention: Chief Executive Officer, or to such other address as either party may
have furnished to the other in accordance herewith, except that notice of change of address shall be effective only upon receipt.

 

13. Applicable
Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without
reference to rules relating to conflict of law. Each of the Consultant and the Company unconditionally and irrevocably consents
to the exclusive jurisdiction and venue of the Supreme Court of the State of New York, New York County and the United States District
Court for the Southern District of New York as the sole venue for any suit, action or proceeding arising out of or relating to
this Agreement, and each of the Consultant and the Company hereby unconditionally and irrevocably waives any objection to venue
in any such court or to assert that any such court is an inconvenient forum, and agrees that service of any summons, complaint,
notice or other process relating to such suit, action or other proceeding may be effected in the manner provided in Section 12
hereof. Each of the Consultant and the Company hereby unconditionally and irrevocably waives the right to a trial by jury in any
such action, suit or other proceeding.

 

14. Successors;
Binding Agreement. This Agreement shall be binding upon any successor (whether direct or indirect, by purchase, merger, consolidation
or otherwise) to all or substantially all of the business and/or assets of the Company, and the Company shall require any such
successor to expressly assume and agree in writing to perform this Agreement in the same manner and to the same extent that the
Company would be required to perform it if no such succession had taken place, or, in the event the Company remains in existence,
the Company shall continue to retain the Consultant under the terms hereof. The Company cannot assign, or delegate its duties under,
this Agreement except (i) pursuant to the immediately preceding sentence, or (ii) to a subsidiary of the Company, provided that
such subsidiary expressly assumes and agrees in writing to perform this Agreement and, in such case, the Company’s liability
to make and provide payments and benefits hereunder shall nevertheless not be discharged thereby. As used in this Agreement, the
“Company” shall mean the Company and any successor to its business and/or assets, which assumes or is obligated
to perform this Agreement by contract, operation of law or otherwise. This Agreement shall inure to the benefit of and be enforceable
by the Consultant and his personal or legal representatives, executors, estate, trustee, administrators, successors, heirs, distributees,
devisees and legatees. The Consultant may not assign this Agreement or any rights hereunder, or delegate his duties under this
Agreement, without the prior written consent of the Company; however, in the event of the death of the Designated Person,
all rights to receive payments hereunder shall become rights of the Designated Person’s devisee, legatee or other designee
or the Designated Person’s estate.

 

    	 	-6-	 

     

    

 

15. Non-Exclusivity
of Rights. Nothing in this Agreement shall limit or otherwise affect such rights as the Consultant may have under any other
contract or agreement entered into after the Commencement Date with the Company.

 

16. Entire
Agreement; Modification. This Agreement constitutes the entire agreement of the parties hereto with respect to the subject
matter hereof and supersedes all prior agreements and undertakings, both written and oral. No provision of this Agreement may be
waived, modified, amended or discharged unless such waiver, modification, amendment or discharge is agreed to in writing and signed
by the Consultant and such officer of the Company as may be specifically designated by the Company. No waiver by either party to
this Agreement at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement
shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.

 

17. Company’s
Representations. The Company represents and warrants that it is free to enter into this Agreement and to perform each of the
terms and covenants of it. The Company represents and warrants that it is not restricted or prohibited, contractually or otherwise,
from entering into and performing this Agreement, and that its execution and performance of this Agreement is not a violation or
breach of, and does not conflict with, any other agreement between the Company and any other person or entity. The Company represents
and warrants that this Agreement is a legal, valid and binding agreement of the Company, enforceable in accordance with its terms.

 

18. Consultant’s
Representations. The Consultant represents and warrants that it is free to enter into this Agreement and to perform each of
the terms and covenants of it. The Consultant and Designated Person represents and warrants that they are not restricted or prohibited,
contractually or otherwise, from entering into and performing this Agreement, and that his execution and performance of this Agreement
is not a violation or breach of, and does not conflict with, any other agreement between the Consultant and any other person or
entity. The Consultant represents and warrants that this Agreement is a legal, valid and binding agreement of the Consultant, enforceable
in accordance with its terms.

 

19. Counterparts.
This Agreement may be executed in multiple counterparts, and/or by the execution of counterpart signature pages that may be attached
to one or more counterparts of this Agreement, and all so executed shall constitute one agreement binding on all of the parties
hereto, notwithstanding that all of the parties hereto are not signatories to the original or the same counterpart. In addition,
any counterpart signature page may be executed by any party hereto wheresoever such party is located, and may be delivered by telephone
facsimile transmission or by any other means of electronic transmission (including by e-mail of PDF copies), and any such facsimile
or electronically transmitted signature page(s) may be attached to one or more counterparts of this Agreement, and such facsimile
or electronically transmitted signature(s) shall have the same force and effect, and be as binding, as if original signatures had
been executed and delivered in person.

 

20. 
Severability. The Company and the Consultant agree that the agreements and provisions contained in this Agreement are severable
and divisible, that each such agreement and provision does not depend upon any other provision or agreement for its enforceability,
and that each such agreement and provision set forth herein constitutes an enforceable obligation between the parties hereto. Consequently,
the parties hereto agree that neither the invalidity nor the unenforceability of any provision of this Agreement shall affect the
other provisions, and this Agreement shall remain in full force and effect and be construed in all respects as if such invalid
or unenforceable provision were omitted.

 

21. Headings;
Construction. The inclusion of headings in this Agreement is for convenience of reference only and shall not affect the construction
or interpretation hereof. The words “Section” and “clause” herein shall refer to provisions of this Agreement,
unless expressly indicated otherwise. The words “include,” “includes” and “including” herein
shall be deemed to be followed by “without limitation” whether or not they are in fact followed by such words or words
of similar import, unless the context otherwise requires. The construction of this Agreement shall not take into consideration
the party who drafted or whose representative drafted any portion of this Agreement, and no canon of construction shall be applied
that resolves ambiguities against the drafter of a document. Each party acknowledges that: (a) it has read this Agreement; (b)
it has been represented in the preparation, negotiation and execution of this Agreement by legal counsel of its own choice; and
(c) it understands the terms and consequences of this Agreement and is fully aware of the legal and binding effect of this Agreement

 

22. Specific
Performance. The Consultant acknowledges that any breach or threatened breach of its covenants contained in this Agreement
could cause the Company material and irreparable damage, the exact amount of which will be difficult to ascertain and that the
remedies at law for any such breach or threatened breach will be inadequate. Accordingly, the Consultant agrees that the Company
shall, in addition to all other available rights and remedies (including, but not limited to, seeking such damages), be entitled
to specific performance and injunctive relief in respect of any breach or threatened breach by the Consultant of any covenants
contained in this Agreement, without being required to post bond or other security and without having to prove the inadequacy of
the available remedies at law or irreparable harm.

 

[SIGNATURE PAGE TO FOLLOW]

 

    	 	-7-	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto, intending to be legally bound, have hereunto executed this Agreement as of the day and year first written above.

 

	 	AVANT DIAGNOSTICS, INC.
	 	 	 
	 	By:	/s/ Scott VanderMeer
	 	Name:	Scott VanderMeer
	 	Title:	Interim CFO
	 	 	 
	 	ADVX INVESTOR GROUP LLC:
	 	 	 
	 	By:	/s/ Jeffrey Busch
	 	Name:	Jeffrey Busch
	 	Title:	President
	 	 	 
	 	By:	/s/ Jeffrey Busch
	 	Name:	Jeffrey Busch

 

 

-8-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]